[Lipid metabolism during a 3-stage program in treating patients with ischemic heart disease].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to V B Iakovlev.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The experience of using special food mixtures for enteral nutrition in treatment of 5518 of the wounded and inpatients allows propose practical conception of using these artificial food mixtures at different pathological situations. The whole characteristics, nutritional and biological values of these mixtures and methodology of their applications are summarized.
Explore the source record for details and available documents.
The article summarizes the results of clinical examination of 992 patients with thromboembolism of lung artery (TLA), its etiology, frequency of development and risk factors. The author describes clinical symptoms of TLA depending on the diameter of the obturated lung arterial vessel. The estimation of special methods was made from the point of view of its diagnostical significance: ECG, chest roentgenography, echocardiography, angiopneumography. The article contains questions concerning pathogenetical treatment and prophylaxis of TLA.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The effectiveness of streptokinase treatment of patients with myocardial infarction as compared to the control group and patients given anticoagulants is analysed. It is shown that the frequency of recurrent myocardial infarctions, congestive circulatory insufficiency, shock, and thromboembolic complications is lower in the group of patients treated with streptokinase than in the control group. Streptokinase improves the course of the disease and the prognosis in patients with preinfarction angina pectoris. The effect of streptokinase is higher in the first 3--6 hours after the development of myocardial infarction and in individuals under the age of 65. The effectiveness of the treatment does not diminish when the drug is injected for a short time and in small doses (300,000--750,000 U).